Navigation Links
BiOptix Continues Support of Antibody Engineering & Therapeutics Research
Date:12/11/2013

BOULDER, Colo. and HUNTINGTON BEACH, Calif., Dec. 11, 2013 /PRNewswire/ -- BiOptix continues support of the global antibody engineering and therapeutics research community through participation in IBC's 24th Annual Antibody Engineering & Therapeutics Conference and annual meeting of The Antibody Society, being held in Huntington Beach, CA from December 8 – 12, 2013.   During the event, BiOptix will be highlighting the BiOptix Innovators Program, a unique and innovative product evaluation platform that allows customers to try BiOptix SPR technology independently in their lab, on their timeframe and with complete customer and technical support during the process. 

While presenting new antibody kinetics data from BiOptix, Ken Wilczek, Vice President, Sales & Marketing for BiOptix noted: "Antibody research and therapeutics continues to be a vital and growing market worldwide—and is a perfect match for the BiOptix 404pi."  "With a unique platform, multiple sensor chemistries and an industry -leading instrumentation demo initiative known as the BiOptix Innovators Program, BiOptix is becoming a principal choice for antibody researchers who require robust and repeatable kinetics."  Additional details about the BiOptix Innovators Program, in which BiOptix seeks to partner with academic, pharmaceutical and biotechnology/drug discovery research labs can be found at:  http://www.bioptix.com/products/innovators-program

Surface Plasmon Resonance is an advanced and highly sensitive optical technology that measures refractive index changes on a sensor chip's gold surface due to a change in mass that occurs during a binding event. This change can be used to monitor biological interactions such as the concentration of target molecules, kinetic rates and affinity constants. BiOptix has developed and patented a novel ultra-sensitive detection platform known as Enhanced Surface Plasmon Resonance, or ESPR. Unlike traditional SPR, ESPR instrumentation from BiOptix enables the high sensitivity of SPR with the high stability and lower noise of common path interferometry.

About BiOptix

BiOptix Diagnostics is a privately held firm based in Boulder, Colorado, with leading investments from Boulder Ventures, Remeditex and Rusnano.  BiOptix has developed a new class of analytical biosensor instrumentation utilizing a patented high-throughput label-free technology known as ESPR – Enhanced Surface Plasmon Resonance. BiOptix instrumentation allows researchers to study label-free protein-protein and protein-small molecule interaction—with high sensitivity and high throughput. Applications include: Protein-small molecule interactions, protein-protein kinetics, antibody affinities and epitope mapping, oligosaccharide characterization, nucleic acid (DNA-DNA or DNA-RNA) hybridization and biomolecule concentration measurements. Additional information about BiOptix and our products can be found at:  www.bioptix.com

 


'/>"/>
SOURCE BiOptix
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. BiOptix continues support of Colorado-based research institutions
2. Celebrating 65 Years of Providing Superior Healthcare Products, Mission Pharmacal Continues to Thrive
3. UV Flu Technologies Continues Aggressive Program to Pay off Convertible Debt
4. AMPAC Fine Chemicals Continues to Invest in Quality Systems
5. Profil Institute Continues to Publish New Findings in Metabolic Research
6. China Cord Blood Corporation Continues Share Repurchase Program
7. Pressure BioSciences, Inc. Continues Global Sales Reach Expansion with Distribution Agreements for China, Vietnam, Laos, Cambodia, Australia, and New Zealand
8. BioStorage Technologies Continues Global Growth; Announces Strategic Expansion Into Asia Pacific and New General Manager APAC
9. Green Coffee Extract Continues Dominance Amongst Summers Top Weight Loss Products
10. Z Trim Holdings Sales Growth Continues in July 2012
11. Z Trim Holdings Sales Growth Continues in August 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... QC , April 20, 2017 /PRNewswire/ - Prometic Life Sciences ... presented new results at the International Liver Congress ("ILC") 2017 ... ("EASL") in Amsterdam on the positive ... a mouse model of obesity and metabolic syndrome. ... According to Dr. Lyne Gagnon, Vice-President ...
(Date:4/20/2017)... and PETACH TIKVAH, Israel , ... a leading developer of adult stem cell technologies for neurodegenerative ... Officer, will present at the Alliance for Regenerative Medicine,s (ARM) ... on Thursday, April 27, 2017 at 09:40 EDT in ... Ralph Kern , MD, MHSc, Chief Medical Officer & Chief ...
(Date:4/19/2017)... ... April 18, 2017 , ... Optofluidics today ... move comes after the company changed focus to making analytical tools for biopharmaceutical ... our new technology,” says CEO Robert Hart. Founders Bernardo Cordovez, Robert Hart and ...
(Date:4/19/2017)... April 19, 2017 A new report published by Allied ... 2014-2022 ," the global market was valued at $6,769 million in 2015, and ... from 2016 to 2022. ... Allied Market Research Logo ...      (Logo: http://photos.prnewswire.com/prnh/20140911/647229) The cross-flow ...
Breaking Biology Technology:
(Date:3/30/2017)... LOS ANGELES , March 30, 2017  On ... Hack the Genome hackathon at ... This exciting two-day competition will focus on developing health ... experience. Hack the Genome is ... has been tremendous. The world,s largest companies in the ...
(Date:3/27/2017)... ROCKVILLE CENTRE, N.Y. , March 27, 2017 ... by Healthcare Information and Management Systems Society (HIMSS) ... Analytics Outpatient EMR Adoption Model sm . In ... top 12% of U.S. hospitals using an electronic ... recognized CHS for its high level of EMR ...
(Date:3/22/2017)... 2017   Neurotechnology , a provider of ... announced the release of the SentiVeillance 6.0 ... facial recognition using up to 10 surveillance, security ... The new version uses deep neural-network-based facial detection ... utilizes a Graphing Processing Unit (GPU) for enhanced ...
Breaking Biology News(10 mins):